体重指数对烧伤后的死亡率和临床结果的影响
Julia Kleinhapl1,2, Rudy Ji3, Lucineia Gainski Danielski1
1Department of Surgery, Division of Surgical Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA.
European burn journal
|February 20, 2026
概括
体重不足的烧伤患者面临更高的死亡率和并发症. 相反,超重和肥胖的个体表现出更好的存活率,支持这一说法.
科学领域:
- 烧伤研究 烧伤研究
- 临床结果 临床结果
- 患者的分层是患者的分层.
背景情况:
- 体重极端影响患者的发病率,但它们对烧伤结果的影响还未得到充分研究.
- 以前的研究表明,在烧伤护理中存在"肥胖悖论",这表明肥胖患者的治疗结果更好.
研究的目的:
- 为了研究身体质量指数 (BMI) 与成年烧伤患者的临床结果之间的关联.
- 根据BMI类别确定不同的风险子组.
主要方法:
- 利用TrinetX现实世界数据库对成年烧伤患者.
- 雇员1: 1倾向得分对人口统计学,烧伤严重程度和吸入烟雾进行匹配.
- 分析了六个月的临床结果,包括死亡率,败血症,肺炎,AKI,心血管事件和心理障碍.
主要成果:
- 体重不足患者的死亡率较高,并增加了败血症,肺炎,心血管事件和心理障碍的风险.
- 超重和肥胖患者与更高的生存率和更好的整体临床结果有关.
- 在体重不足与正常,超重与正常,肥胖与正常以及体重不足与肥胖的比较中,获得了显著的样本大小.
结论:
- 这些发现与烧伤护理中的"肥胖悖论"一致.
- 体重不足的烧伤患者是高风险的子组,需要特别注意.
- 体重指数 (BMI) 是影响烧伤患者结果的关键因素.
相关概念视频
Burn Injuries
4.8K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.8K
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
312
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
312
Drug Dosing: Obese Patients
301
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
301
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
491
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
491


